Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Rev. Soc. Bras. Med. Trop ; 54: e20200208, 2021. graf
Article Dans Anglais | SES-SP, ColecionaSUS, LILACS | ID: biblio-1143878

Résumé

Abstract Post-kala-azar dermal leishmaniasis is a skin disorder occurring in 5-10% of visceral leishmaniasis patients after treatment with miltefosine,the first-line drug for this skin disorder. We reported a case of acute anterior uveitis,a rare adverse effect, experienced by a patient treated with miltefosine for post-kala-azar dermal leishmaniasis. This adverse effect developed after 15 days of miltefosine consumption, and the patient himself discontinued the treatment. The ophthalmic complication was completely resolved with antibiotics and steroid eye drops. After recovery from the ophthalmic complication, the patient was successfully treated with liposomal amphotericin B for the skin lesions.


Sujets)
Humains , Uvéite/induit chimiquement , Uvéite/traitement médicamenteux , Leishmaniose cutanée/traitement médicamenteux , Leishmaniose viscérale/complications , Leishmaniose viscérale/traitement médicamenteux , Antiprotozoaires/effets indésirables , Phosphoryl-choline/analogues et dérivés
SÉLECTION CITATIONS
Détails de la recherche